Clinical Research Directory

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Sponsor: Keymed Biosciences Co.Ltd

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of Stapokibart Injection in the treatment of subjects with prurigo nodularis, and observe pharmacokinetic characteristics, pharmacological effects, and immunogenicity.

Official title: A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of Stapokibart Injection in Subjects With Prurigo Nodularis

Key Details

Conditions

Interventions

Locations (1)